Oncology Alliance Launches Multicancer Early Detection Biobank Study
The Alliance for Clinical Trials in Oncology announced a new study that aims to assess the utility of early cancer detection blood tests.
Read More
Search Results for: prostate cancer
New Liquid Biopsy Uses Droplets of Blood for Cancer Analysis
A new blood test provides unprecedented insight into a patient’s cancer make-up, allowing doctors to better select patient treatment options.
Read More
Nanostics Launches Study to Identify Potent Disease Predictors for Early Bladder Cancer Detection
Nanostics launched a prospective clinical study designed to validate a novel and minimally invasive bladder cancer diagnostic test.
Read More
Urine-Based Molecular Test for Prostate Cancer Available
miR Sentinel is a novel, urine-based molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm.
Read More
Nanostics’ Prostate Test Helps Assess Patient Biopsy Needs, Study Shows
Nanostics’ ClarityDX Prostate test is designed to improve the accuracy of detecting significant prostate cancer in men at risk of the disease.
Read More